Recent studies have revealed that hyperlipidemia, characterized by elevated levels of low-density lipoprotein cholesterol, very-low-density lipoprotein cholesterol, and apolipoprotein B (ApoB), directly promotes the onset and progression of atherosclerosis, making it a key pathogenic factor in ASCVD (Correction, 2023). Here, APOB is linked to hyperlipidemia.